Syneos Health Acquires Synteract from Amulet Capital Partners

December 10, 2020

Syneos Health (NASDAQ: SYNH) has completed the acquisition of Synteract, a full-service contract research organization (CRO) focused on emerging biopharma. The seller was Amulet Capital Partners, which had previously built Synteract through organic investment and add-on acquisitions.

Buyers
Syneos Health
Targets
Synteract
Sellers
Amulet Capital Partners
Location
North Carolina, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.